---
title: "Regulus Therap (RGLS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RGLS.US/norm.md"
symbol: "RGLS.US"
name: "Regulus Therap"
parent: "https://longbridge.com/en/quote/RGLS.US.md"
datetime: "2026-03-13T20:54:26.550Z"
locales:
  - [en](https://longbridge.com/en/quote/RGLS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGLS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGLS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/RGLS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RGLS.US/norm.md)


# Regulus Therap (RGLS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1456 | -0.1953 | -0.2148 | -0.1712 | -0.2946 |
| ROE | -53.00% | -62.70% | -60.82% | -42.91% | -52.62% |
| Revenue | - | - | - | - | - |
| Net income | -9.63M | -12.79M | -14.06M | -11.04M | -8.47M |

## Balance Sheet (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 74.83M | 84.18M | 93.76M | 104.12M | 114.14M |
| Leverage | 1.08 | 1.10 | 1.08 | 1.06 | 1.06 |
| BVPS | 1.04 | 1.17 | 1.33 | 1.50 | 1.64 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -10.61M | -11.85M | -9.45M | -11.64M | -8.74M |
| Investing CF | 21.50M | 24.00M | 18.64M | -83000.00 | -78.54M |
| Financing CF | 45000.00 | 0.0000 | 56000.00 | -744000.00 | 93.11M |
| Free CF | -6.33M | -7.23M | -4.32M | -7.67M | -6.21M |